XAIR.NASDAQBeyond Air, INC

Form 4: Beyond Air Director's Options Repriced to $1.95

Sentiment:

Insider Transaction Report


Beyond Air, Inc. director Robert Scott Goodman's stock options were repriced from $10.80 to $1.95 per share, effective November 4, 2025.

Worse than expectedThe repricing of stock options from $10.80 to $1.95 per share indicates a significant decline in the company's stock value, suggesting that the original options were substantially underwater.This action implies that the company's stock performance has been worse than initially anticipated when the options were first granted.

Summary

  • Robert Scott Goodman, a Director of Beyond Air, Inc. (XAIR), had 187 of his stock options repriced.
  • The repricing was approved by the Issuer's Board of Directors and became effective on November 4, 2025.
  • The exercise price for these options was reduced from $10.80 per share to $1.95 per share.
  • The new exercise price of $1.95 per share was based on the closing price of Beyond Air's common stock on November 3, 2025.
  • All other terms of the options, including the vesting schedule, remain unchanged.
  • The stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan.

Sentiment

Score: 4

Explanation: The repricing of options, while beneficial for the insider, generally reflects negatively on the company's past stock performance and can be perceived as a negative signal by the market, indicating a need to reset incentives due to a significant drop in share price.

Positives

  • For Robert Scott Goodman, the repricing significantly lowers the exercise price of his stock options, making them more likely to be in-the-money and providing a renewed incentive for his continued service.

Negatives

  • The repricing indicates a substantial decline in Beyond Air's stock price, as the original options with an exercise price of $10.80 were likely significantly underwater.
  • Option repricings can be viewed negatively by existing shareholders as they may signal poor past performance or potential future dilution if the stock recovers.

Future Outlook

The filing indicates that the stock options will become exercisable in accordance with the vesting schedule specified in the award agreement and subject to the reporting person's continued service with the Issuer.

Industry Context

This insider transaction, specifically an option repricing, reflects a company-specific event rather than a broad industry trend. However, option repricings often occur in sectors where stock performance has been challenging, potentially indicating difficulties within the medical device or biotechnology industry for Beyond Air, Inc.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PolicyThe Issuer's Board of Directors approved an option repricing for a director, reducing the exercise price of 187 stock options from $10.80 to $1.95 per share.11/04/2025This action demonstrates the Board's decision to adjust executive incentives in response to changes in the company's stock valuation, potentially aiming to retain key personnel and realign their interests with future stock performance.

Related Party Transactions

  • The repricing of stock options for Robert Scott Goodman, a Director of Beyond Air, Inc., constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: May experience a negative perception due to the underlying stock price decline that necessitated the repricing, and potential future dilution if the repriced options are exercised.
  • Director (Robert Scott Goodman): Benefits from a significantly lower exercise price, enhancing the potential value of his equity compensation and providing renewed incentive.

Next Steps

  • The stock options will vest according to the schedule specified in the award agreement, contingent on Robert Scott Goodman's continued service with Beyond Air, Inc.

Key Dates

DateDescription
11/03/2025Closing price of Beyond Air's common stock ($1.95) used as the basis for the new option exercise price.
11/04/2025Date the Issuer's Board of Directors approved the option repricing and the effective date of the repricing.
11/06/2025Signature date of the reporting person on the Form 4 filing.

Keywords

Beyond Air, XAIR, stock options, option repricing, insider transaction, Form 4, Robert Scott Goodman, equity incentive plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.